fucidin-hydrocortison krem 20 + 10 mg
leo pharma a/s* - acidum fusidicum inn; hydrocortisonum acetat - krem - 20 + 10 mg
spectracillin filmuhúðuð tafla 875/125 mg
williams & halls ehf. - acidum clavulanicum kalíum; amoxicillinum tríhýdrat - filmuhúðuð tafla - 875/125 mg
duoplavin
sanofi winthrop industrie - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - blóðþurrðandi lyf - duoplavin er ætlað til að koma í veg fyrir beinþrýstingslækkandi aukaverkanir hjá fullorðnum sjúklingum sem taka bæði klópídógrel og asetýlsalisýlsýru (asa). duoplavin is a fixed-dose combination medicinal product for continuation of therapy in:non st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention (pci);st segment elevation acute myocardial infarction (stemi) in patients undergoing a stent placement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. nánari upplýsingar er að vísa til kafla 5.
xylocain stungulyf, lausn 10 mg/ml
aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 10 mg/ml
xylocain stungulyf, lausn 20 mg/ml
aspen pharma trading limited - lidocainum hýdróklóríð - stungulyf, lausn - 20 mg/ml
xylocain adrenalin stungulyf, lausn 10 mg/ml+5 míkróg/ml
aspen pharma trading limited - lidocainum hýdróklóríð; adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 10 mg/ml+5 míkróg/ml
mycofenolsýra accord (mycofenolsýra accord healthcare) magasýruþolin tafla 180 mg
accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 180 mg
mycofenolsýra accord (mycofenolsýra accord healthcare) magasýruþolin tafla 360 mg
accord healthcare b.v. - mycophenolatum natríum - magasýruþolin tafla - 360 mg
sibnayal
advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - Ónæmisbælandi lyf - vinsamlegast skoðaðu kafla 4. 1 af samantekt á eiginleikum vöru í upplýsingaskjalinu.